Hepatitis C infection and disease

丙型肝炎影响了25万澳大利亚人，导致潜伏但不断发展的肝病，最终导致肝功能衰竭或癌症。目前还没有疫苗，预防计划的效果也有限，但新的抗病毒疗法现在提供了很高的治愈率。该计划将评估通过更好地了解病毒和人体免疫反应(包括疤痕形成和肝癌形成)来改善感染者健康和防止新感染的战略。

Hepatitis C affects a quarter of a million Australians, causing insidious but progressive liver disease which culminates in liver failure or cancer. There is no vaccine and prevention programs have limited effectiveness, but new antiviral therapies now offer high rates of cure. This Program will evaluate strategies to improve the health of those affected and prevent new infections by better understanding of the virus and the body’s immune response, including scarring and liver cancer formation.